发明名称 METHODS OF ENHANCING FUNCTIONING OF THE LARGE INTESTINE
摘要 The invention relates to glucagon-related peptides and their use for the prevention or treatment of disorders involving the large intestine. In particular, it has now been demonstrated that GLP-2 and peptidic agonists of GLP-2 can cause proliferation of the tissue of large intestine. Thus, the invention provides methods of proliferating the large intestine in a subject in need thereof. Further, the methods of the invention are useful to treat or prevent inflammatory conditions of the large intestine, including inflammatory bowel diseases.
申请公布号 US2015290295(A1) 申请公布日期 2015.10.15
申请号 US201514685363 申请日期 2015.04.13
申请人 1149336 Ontario Inc. 发明人 Drucker Daniel J.
分类号 A61K38/26;A61K49/00;C07K14/605 主分类号 A61K38/26
代理机构 代理人
主权项 1. A method for treating a subject to enhance functioning of the large intestine, comprising the step of delivering to the large intestine of the subject a GLP-2 receptor agonist in an amount effective to enhance functioning of the large intestine.
地址 Toronto CA